tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1

Compare Vertex Pharmaceuticals (VX1) vs. Competitors

Compare
23 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
€395.20
€99.50B
29.32
-15.83%
22 Buy
3 Hold
0 Sell
Strong Buy
Alnylam Pharma
$312.17
$41.40B
166.04
23.12%
16 Buy
3 Hold
0 Sell
Strong Buy
Incyte
$90.78
$18.07B
14.98
49.85%
8 Buy
8 Hold
1 Sell
Moderate Buy
Regeneron
$756.91
$77.47B
17.92
10.60%
18 Buy
5 Hold
0 Sell
Strong Buy
Argenx Se
$663.93
$41.95B
39.77
8.30%
17 Buy
2 Hold
0 Sell
Strong Buy
BioNTech SE
$89.27
$22.44B
-7.23%
13 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:VX1
Vertex Pharmaceuticals
395.20
-78.70
-16.61%
ALNY
Alnylam Pharma
312.17
21.47
7.39%
INCY
Incyte
90.78
28.00
44.60%
REGN
Regeneron
732.87
75.46
11.48%
ARGX
Argenx Se
663.93
55.98
9.21%
BNTX
BioNTech SE
89.27
-11.37
-11.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts